Ligand's Bullish Wedge Touches Price Support
Ligand Pharmaceutical (LGND) broke out above price resistance in April with solid volume confirmation. But the stock was extremely overbought and in need of a pullback to unwind its momentum oscillators. RSI had touched the 80s with stochastic elevated in the 90s. LGND has lost approximately 12%-13% over the past six weeks as a bullish wedge has formed to drop the price back to price support from the April breakout. Check it out:

The black arrow now shows the RSI near 40 and stochastic at 24, a much better reward to risk entry point.
Happy trading!
Tom